Statistics for Multicenter Phase 2 Trial of Rituximab for Waldenström Macroglobulinemia (WM): An Eastern Cooperative Oncology Group Study (E3A98)

Total visits

views
Multicenter Phase 2 Trial of Rituximab for Waldenström Macroglobulinemia (WM): An Eastern Cooperative Oncology Group Study (E3A98) 8

Total visits per month

views
August 2023 8
September 2023 0
October 2023 0
November 2023 0
December 2023 0
January 2024 0
February 2024 0

Top country views

views
United States 8

Top city views

views
Newark 8